Ginkgo Bioworks Holdings (DNA) Retained Earnings (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Retained Earnings of $1.2 million for Q1 2026, down 35.49% on a QoQ basis from $1.9 million in Q4 2025, and down 99.98% year-over-year from $6.6 billion in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Retained Earnings (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Retained Earnings history runs 7 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- Quarterly Retained Earnings fell 99.98% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 99.98% YoY) and the FY2025 annual result came in at $1.9 million, up 202.49% from the prior year.
- Retained Earnings was $1.2 million for Q1 2026 at Ginkgo Bioworks Holdings, down from $1.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at $6.6 billion in Q1 2025 and bottomed at -$5.7 billion in Q3 2024.
- A 5-year average of -$134.6 million and a median of $1.2 million in 2026 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 57832.02% — and 2024, when it surged 399422.06%.
- Ginkgo Bioworks Holdings' Retained Earnings stood at -$4.4 billion in 2022, then soared by 245.22% to $6.4 billion in 2023, then slumped by 100.03% to -$1.8 million in 2024, then surged by 202.49% to $1.9 million in 2025, then slumped by 35.49% to $1.2 million in 2026.
- Business Quant data shows DNA's Retained Earnings at $1.2 million in Q1 2026, $1.9 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | 1.85 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 6.58 Bn |
| Dec 31, 2024 | -1.81 Mn |
| Sep 30, 2024 | -5.73 Bn |
| Jun 30, 2024 | -5.67 Bn |
| Mar 31, 2024 | 6.45 Bn |
| Dec 31, 2023 | 6.39 Bn |
| Sep 30, 2023 | -5.08 Bn |
| Jun 30, 2023 | 6.28 Bn |
| Mar 31, 2023 | -1.61 Mn |
| Dec 31, 2022 | -4.40 Bn |
| Sep 30, 2022 | -4.22 Bn |
| Jun 30, 2022 | 5.20 Mn |
| Mar 31, 2022 | -2.88 Bn |
| Dec 31, 2021 | -2.30 Bn |
| Sep 30, 2021 | -697.27 Mn |
| Jun 30, 2021 | 105.99 Mn |